A safety and efficacy study of Velphoro for treating hyperphosphataemia in adults in China .
Phase of Trial: Phase I/II
Latest Information Update: 19 Mar 2018
Price : $35 *
At a glance
- Drugs Sucroferric oxyhydroxide (Primary)
- Indications Hyperphosphataemia
- Focus Adverse reactions; Therapeutic Use
- 19 Mar 2018 New trial record
- 15 Mar 2018 According to a Vifor Pharma media release, company expected to conduct this study in 2018 in china.